JP2015502915A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015502915A5 JP2015502915A5 JP2014534890A JP2014534890A JP2015502915A5 JP 2015502915 A5 JP2015502915 A5 JP 2015502915A5 JP 2014534890 A JP2014534890 A JP 2014534890A JP 2014534890 A JP2014534890 A JP 2014534890A JP 2015502915 A5 JP2015502915 A5 JP 2015502915A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- antigen
- binding portion
- isolated antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161547307P | 2011-10-14 | 2011-10-14 | |
| US61/547,307 | 2011-10-14 | ||
| AU2011904190 | 2011-10-14 | ||
| AU2011904190A AU2011904190A0 (en) | 2011-10-14 | Antibodies to CD1d | |
| PCT/AU2012/001247 WO2013053021A1 (en) | 2011-10-14 | 2012-10-15 | ANTIBODIES TO CD1d |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015502915A JP2015502915A (ja) | 2015-01-29 |
| JP2015502915A5 true JP2015502915A5 (enExample) | 2015-12-03 |
Family
ID=48081279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014534890A Pending JP2015502915A (ja) | 2011-10-14 | 2012-10-15 | ＣＤ１ｄに対する抗体 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20140286957A1 (enExample) |
| EP (1) | EP2766042A4 (enExample) |
| JP (1) | JP2015502915A (enExample) |
| KR (1) | KR20140108520A (enExample) |
| CN (1) | CN104144700B (enExample) |
| AU (1) | AU2012323781B8 (enExample) |
| BR (1) | BR112014008691A2 (enExample) |
| CA (1) | CA2850961A1 (enExample) |
| EA (1) | EA201400447A1 (enExample) |
| IL (1) | IL231975A0 (enExample) |
| MX (1) | MX2014004326A (enExample) |
| SG (1) | SG11201400521PA (enExample) |
| WO (1) | WO2013053021A1 (enExample) |
| ZA (1) | ZA201401776B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201706128PA (en) | 2015-01-27 | 2017-08-30 | Lava Therapeutics B V | Single domain antibodies targeting cd1d |
| CN109476724B (zh) * | 2016-04-08 | 2023-04-04 | 艾达普特免疫有限公司 | T细胞受体 |
| DK3440105T3 (da) * | 2016-04-08 | 2022-06-13 | Immunocore Ltd | T-cellereceptorer |
| SG11201808751SA (en) * | 2016-04-08 | 2018-11-29 | Adaptimmune Ltd | T cell receptors |
| CN108079292A (zh) * | 2016-11-23 | 2018-05-29 | 苏州盛迪亚生物医药有限公司 | 一种抗pd-1抗体在制备治疗肝癌的药物中的用途 |
| AU2018234827B2 (en) * | 2017-03-15 | 2024-04-04 | Orca Biosystems Inc. | Compositions and methods for hematopoietic stem cell transplants |
| BR112021005184A8 (pt) * | 2018-09-19 | 2022-08-16 | Lava Therapeutics B V | Imunoglobulina cd1d de dupla ação |
| GB201820006D0 (en) | 2018-12-07 | 2019-01-23 | Lifearc | Humanised anti-IL17BR antibody |
| US11725052B2 (en) * | 2020-08-18 | 2023-08-15 | Cephalon Llc | Anti-PAR-2 antibodies and methods of use thereof |
| US20240050569A1 (en) * | 2020-12-18 | 2024-02-15 | Bioardis, Llc | Mesothelin binding molecules and uses thereof |
| CN120476137A (zh) | 2022-08-18 | 2025-08-12 | 英美偌科有限公司 | 对mage a4具有特异性的t细胞受体融合蛋白 |
| CN116217704B (zh) * | 2022-10-25 | 2025-08-15 | 南京医科大学 | 一种抑制肝细胞凋亡的表面分子及其应用 |
| WO2024137789A2 (en) * | 2022-12-21 | 2024-06-27 | Board Of Regents, The University Of Texas System | Cd3 and itcr expressing engineered natural killer cells with enhanced function for adoptive immunotherapy |
| WO2024226794A1 (en) * | 2023-04-26 | 2024-10-31 | The Trustees Of Indiana University | Composition and methods for treatment of spinal cord injury and traumatic brain injury |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1095062B1 (en) * | 1998-07-09 | 2006-09-13 | Brian J. Nickoloff | Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands |
| US8084020B2 (en) * | 2002-05-01 | 2011-12-27 | Beth Israel Deaconess Medical Center | Use of anti-CD1 antibodies for the modulation of immune responses |
| WO2008100912A1 (en) * | 2007-02-12 | 2008-08-21 | The General Hospital Corporation | Methods for attenuating allergen-induced airway hyperreactivity using cd1d dependent antagonists |
| US8012484B2 (en) * | 2007-04-12 | 2011-09-06 | University Of Virginia Patent Foundation | Method of treating ischemia reperfusion injury by inhibiting NKT cell activity |
-
2012
- 2012-10-15 JP JP2014534890A patent/JP2015502915A/ja active Pending
- 2012-10-15 CA CA2850961A patent/CA2850961A1/en not_active Abandoned
- 2012-10-15 CN CN201280050432.2A patent/CN104144700B/zh not_active Expired - Fee Related
- 2012-10-15 EA EA201400447A patent/EA201400447A1/ru unknown
- 2012-10-15 WO PCT/AU2012/001247 patent/WO2013053021A1/en not_active Ceased
- 2012-10-15 KR KR1020147012848A patent/KR20140108520A/ko not_active Withdrawn
- 2012-10-15 AU AU2012323781A patent/AU2012323781B8/en not_active Ceased
- 2012-10-15 MX MX2014004326A patent/MX2014004326A/es unknown
- 2012-10-15 EP EP12840164.3A patent/EP2766042A4/en not_active Withdrawn
- 2012-10-15 BR BR112014008691A patent/BR112014008691A2/pt unknown
- 2012-10-15 SG SG11201400521PA patent/SG11201400521PA/en unknown
-
2014
- 2014-03-11 ZA ZA2014/01776A patent/ZA201401776B/en unknown
- 2014-04-07 IL IL231975A patent/IL231975A0/en unknown
- 2014-04-10 US US14/249,566 patent/US20140286957A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015502915A5 (enExample) | ||
| JP2009533020A5 (enExample) | ||
| JP2012525829A5 (enExample) | ||
| RU2008137763A (ru) | Связующий элемент для рецептора gm-csf | |
| RU2017137872A (ru) | Композиции для ингибирования masp-2-зависимой активации комплемента | |
| HRP20210739T1 (hr) | Molekule koje vežu antigen i sadrže trimer obitelji tnf liganada | |
| HRP20150623T1 (hr) | Monoklonalno protutijelo sposobno za vezivanje na specifiäśni diskontinuirani epitop koji se pojavljuje u podruäśju ad1 od humanog glikoproteina citomegalovirusa gb, te njegov fragment koji se veže na antigen | |
| JP2012502649A5 (enExample) | ||
| JP2014534242A5 (enExample) | ||
| RU2017128882A (ru) | Антитела к биотину и способы их применения | |
| JP2017052784A5 (enExample) | ||
| JP2015504306A5 (enExample) | ||
| JP2011173884A5 (enExample) | ||
| HRP20191219T1 (hr) | Molekule protutijela koje imaju specifičnost za ljudski ox40 | |
| PE20181952A1 (es) | Anticuerpos anti-ll-33, composiciones, metodos y usos de los mismos | |
| JP2012530496A5 (enExample) | ||
| JP2013502204A5 (enExample) | ||
| JP2020504101A5 (enExample) | ||
| JP2012511329A5 (enExample) | ||
| RU2020129387A (ru) | Антитела к pd-1 собак | |
| JP2011519571A5 (enExample) | ||
| IL265434B1 (en) | Anti-cd27 antibodies | |
| JP2013198490A5 (enExample) | ||
| JP2014526898A5 (enExample) | ||
| ME02678B (me) | Antitijela na ox-40 i postupci njihove primjene |